By Mr Maarten Meulenbelt, Sidley Austin LLP* In the pharmaceutical industry, the role of Intellectual Property (IP) as an incentive for product development is particularly important: each investor...

By Dr. Kevin E. Noonan, McDonnell Boehnen Hulbert & Berghoff LLP The current SARS-CoV-2 and the COVID pandemic is the greatest global health threat caused by a virus since the influenza...

We asked ECIPE experts to help compile a list of books to read over the summer. The goal was to recommend literature that helps readers make sense of the troubled times we are living in right now,...

A street pharmacy in Tanzania (from author’s own archives) Debt relief is not a panacea to tackle the pandemic in the developing countries In midst of the corona-crisis, the world's twenty largest...

The trade answer to the coronavirus crisis has been a mix of openness and protectionism. Countries have lowered import duties (examples here, here, and here), imposed export restrictions (here and...

Covid-19 has hit the world very hard in general and some regions so far in particular (e.g. China, Europe, US) over the past three months. The deep level of interconnectedness between countries and...

It is certain that the world will overcome the COVID-19 crisis, as much as it is certain that in the aftermath the world will look different with regards to global trade. International trade patterns...

We are at war. But this war is different. There is no visible enemy, no border, no ideological divide. And yet, as in the past century’s conflicts, our lifestyle changed, our habits are hit by...

Introduction The bravest prediction in the midst of a crisis is that nothing will change as a result. Typically at such times, the optimists hope that a crisis will be the incentive to fix the...

I’m not a coronavirus expert. Trade, economics and politics is my field. I had to look up the spelling of epidemiologist for this article and I’m definitely not one. But just as trade deals are...